HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gastric Helicobacter infection inhibits development of oral tolerance to food antigens in mice.

Abstract
The increase in the transcellular passage of intact antigens across the digestive epithelium infected with Helicobacter pylori may interfere with the regulation of mucosal immune responses. The aim of this work was to study the capacity of Helicobacter infection to inhibit the development of oral tolerance or to promote allergic sensitization and the capacity of a gastro-protective agent, rebamipide, to interfere with these processes in mice. Oral tolerance to ovalbumin (OVA) was studied in 48 C3H/He 4-week-old mice divided into four groups: (i) OVA-sensitized mice; (ii) OVA-"tolerized" mice (that is, mice that were rendered immunologically tolerant); (iii) H. felis-infected, OVA-tolerized mice; (iv) and H. felis-infected, OVA-tolerized, rebamipide-treated mice. Oral sensitization to hen egg lysozyme (HEL) was studied in 48 mice divided into four groups: (i) controls; (ii) HEL-sensitized mice; (iii) H. felis-infected, HEL-sensitized mice; and (iv) H. felis-infected, HEL-sensitized, rebamipide-treated mice. Specific anti-OVA or anti-HEL immunoglobulin E (IgE) and IgG1/IgG2a serum titers were measured by enzyme-linked immunosorbent assay. Additionally, the capacity of rebamipide to interfere with antigen presentation and T-cell activation in vitro, as well as absorption of rebamipide across the epithelial monolayer, was tested. H. felis infection led to the inhibition of oral tolerance to OVA, but rebamipide prevented this inhibitive effect of H. felis. H. felis infection did not enhance the sensitization to HEL, but rebamipide inhibited the development of this sensitization. Moreover, rebamipide inhibited in a dose-dependent manner antigen presentation and T-cell activation in vitro and was shown to be able to cross the epithelium at a concentration capable of inducing this inhibitory effect. We conclude that H. felis can inhibit the development of oral tolerance to OVA in mice and that this inhibition is prevented by rebamipide.
AuthorsTamara Matysiak-Budnik, Guillaume van Niel, Francis Mégraud, Kathryn Mayo, Claudia Bevilacqua, Valérie Gaboriau-Routhiau, Marie-Christiane Moreau, Martine Heyman
JournalInfection and immunity (Infect Immun) Vol. 71 Issue 9 Pg. 5219-24 (Sep 2003) ISSN: 0019-9567 [Print] United States
PMID12933867 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens
  • Immunoglobulin G
  • Quinolones
  • Immunoglobulin E
  • Ovalbumin
  • Muramidase
  • rebamipide
  • Alanine
Topics
  • Administration, Oral
  • Alanine (analogs & derivatives, pharmacology)
  • Anaphylaxis (etiology)
  • Animals
  • Antigen Presentation (drug effects)
  • Antigens (administration & dosage)
  • Chickens
  • Female
  • Gastritis (immunology)
  • Helicobacter Infections (immunology)
  • Immune Tolerance
  • Immunity, Mucosal
  • Immunoglobulin E (biosynthesis)
  • Immunoglobulin G (biosynthesis)
  • In Vitro Techniques
  • Intestines (drug effects, immunology)
  • Mice
  • Mice, Inbred C3H
  • Muramidase (immunology)
  • Ovalbumin (administration & dosage, immunology)
  • Quinolones (pharmacology)
  • T-Lymphocytes (drug effects, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: